Tonix Pharmaceuticals Holding (STU:TPM0) Change In Payables And Accrued Expense : €1.75 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Tonix Pharmaceuticals Holding Change In Payables And Accrued Expense?

Tonix Pharmaceuticals Holding's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was €1.13 Mil. It means Tonix Pharmaceuticals Holding's Accounts Payable & Accrued Expense increased by €1.13 Mil from Dec. 2023 to Mar. 2024 .

Tonix Pharmaceuticals Holding's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €-1.56 Mil. It means Tonix Pharmaceuticals Holding's Accounts Payable & Accrued Expense declined by €1.56 Mil from Dec. 2022 to Dec. 2023 .

Tonix Pharmaceuticals Holding Change In Payables And Accrued Expense Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding Change In Payables And Accrued Expense Chart

Tonix Pharmaceuticals Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

1.91

3.65

4.67

0.15

-1.56

Tonix Pharmaceuticals Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-2.23	0.20	-0.03	0.45	1.13

Tonix Pharmaceuticals Holding Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.75 Mil.

Tonix Pharmaceuticals Holding Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonix Pharmaceuticals Holding (STU:TPM0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (STU:TPM0) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

TNXP:USA

Address

26 Main Street, Suite 101, Chatham, NJ, USA, 07928

Website

https://www.tonixpharma.com

Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (STU:TPM0) Headlines

No Headlines